ReviewBioengineering (Basel, Switzerland)2026
Anionic Polysaccharides: Promising 3D Bioink Candidates for Tissue Engineering.
Review in Bioengineering (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Anionic polysaccharides are sugars with a negative charge. Common examples include alginic acid, hyaluronic acid, pectin, chondroitin sulfate, and heparin. These molecules are bioactive and widely used in medicine, food, and cosmetics. On their own, they usually do not bind to cells. However, they can serve as bioinks or as parts of bioink mixtures. In 3D bioprinting, anionic polysaccharides are often combined with natural polymers like collagen or with synthetic materials to form hydrogels. These hydrogels act as scaffolds that give cells a three-dimensional space to grow and form tissue. The properties of these hydrogels can be tuned to match specific needs. Together, anionic polysaccharides and 3D bioprinting offer strong potential for tissue engineering, making it possible to build complex, custom tissue structures that may help solve problems in organ repair and replacement. This review summarizes the sources, structures, and key properties of Common anionic polysaccharides, with a comparative analysis of their chemical, biological, and mechanical characteristics and recent 3D printing strategies. It highlights the advantages of anionic polysaccharide bioinks, particularly their compatibility with enzymatic, photo-, and ionic crosslinking, and presents representative examples demonstrating their suitability for diverse tissue engineering applications and printing requirements.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.